Hila Magen

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.

Jessica Katz, Hermann Einsele, Paul Richardson, 2015, The New England journal of medicine.

Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment

Eli Muchtar, H. Magen, Eli Muchtar, 2016, Therapeutic advances in hematology.

Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma

Amos Tanay, Eyal David, Arnon Nagler, 2018, Nature Medicine.